FDA Drug Application (020130) for ESTROSTEP 21 by APIL

Back to FDA Applications sponsored by APIL

Application Number020130
Product Number001
FormTABLET;ORAL-21
Dosage0.02MG;0.035MG;0.03MG;1MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameESTROSTEP 21
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by APIL